X

Transchem Ltd Stock Analysis

Small Cap
Evaluated by 82 users | BSE: 500422 | NSE: TRANSCHEM |
Agriculture
Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.The company is the largest...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed -3.37%-1.7%-1.29%-1.64%0.31%-2.92%-3.35%-4.92%0.44%1.03%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0000000000
Y-o-Y Gr. Rt.-NANANANANANANANANA
Adjusted EPS (Rs.) -1.34-0.74-0.59-0.550.1-0.91-1.05-1.50.140.31
Y-o-Y Gr. Rt.-NANANANA-1010%NANANA121.4%
Book Value per Share (Rs.) 35.6932.9731.8931.2331.3331.3731.0430.0731.0330.04
Adjusted Net Profit -1.6-0.9-0.7-0.70.1-1.1-1.3-1.80.20.4
Net Op. Cash Flow (Rs. Cr.) -5.51.21.80.60.91.10.6-19.810.3-0.6
Debt to Cash Flow from Ops -0.552.570.90000000
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Transchem Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales NANANANA
Adjusted EPS NA25.4%NA121.4%
Book Value per Share -1.9-0.8-1.1-3.2
Share Price 0.5% 1.7% -19.1% -3.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) -3.63-2.15-1.82-1.750.31-2.92-3.35-4.920.441.03
Operating Profit Margin (%) 0000000000
Net Profit Margin (%) 0000000000
Debt to Equity 0.070.070.040000000
Working Capital Days 0000000000
Cash Conversion Cycle 0000000000
Entity Percentage Holding
Promoters 39.29%
Institutions 0.03%
Non-Institutions 60.68%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Transchem Ltd's performance infers:

Transchem Ltd earnings have grown by 25.4%, whereas share price has appreciated 1.7% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Transchem Ltd share prices over the last 10 years. Here is what we found out:

Transchem Ltd share price has appreciated 2.3% annually over the past ten years.

Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.

The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use API’s.

The

Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.

The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use API’s.

The company is having four state of the art GMP approved facilities at multiple locations in India, with total production capacity of 500 MT per annum.

The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.

Products and services offered by the company:

Services:

  • Contract Research Facility.
  • Custom Synthesis of Molecules.
  • Contract Manufacturing of API's as per GMP Guidelines.
  • Intermediates.
  • Veterinary Formulations.
  • Q.A. & Regulatory Support.

Product:

Anthelmintics

  • Albendazole USP / EP /BP
  • Ricobendazole (Albendazole Sulphoxide)
  • Mebendazole EP / BP / USP / POLY 'C'
  • Oxyclozanide BP VET
  • Closantel Sodium EP / BASE
  • Clorsulon USP
  • Nitroscanate
  • Fenbendazole EP/BP/BP VET
  • Oxfendazole BP VET / EP
  • Flubendazole EP / 98%
  • Nitroxynil BP VET
  • Rafoxanide BP VET
  • Triclabendazole
  • Praziquantel BP / USP

Veterinary API's

  • Diminazene Diaceturate B VET C
  • Quinapyramine Salts B VET C
  • Parvaquone
  • Toldimfos Sodium
  • Acepromazine Maleate BP VET
  • Butaphosphan
  • Flunixin Meglumine USP
  • Homidium Bromide / Chloride
  • Isometamedium

Ectoparaciticides

  • Cyromazine.
  • Cymiazole
  • S-Methoprene
  • Azamethiphos.

Human Use API's

  • Ramipril EP
  • Frusemide EP / BP / USP
  • Gabapentin USP
  • Cetirizine DI HCL EP/BP
  • Lamotrigine
  • Pentamidine Isetionate BP
  • Succinylcholine Chloride USP
  • Epinastine HCL
  • Nifuroxazide
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback